Showing results (111-120 of 238) with videos related to
Sort By:
Pageof 24
Neuroendocrinology|July 19, 2019
Effect of the Tryptophan Hydroxylase Inhibitor Telotristat on Growth and Serotonin Secretion in 2D and 3D Cultured Pancreatic Neuroendocrine Tumor CellsAura D Herrera-Martínez, Richard A Feelders, Rosanna Van den Dungen, et al.Clinical Medicine. Oncology|September 6, 2011
Malignant struma ovarii: good response after thyroidectomy and I ablation therapyErica W M Janszen, Helena C van Doorn, Patricia C Ewing, et al.Endocrine-Related Cancer|March 22, 2017
Pitfalls in the response evaluation after peptide receptor radionuclide therapy with [<sup>177</sup>Lu-DOTA<sup>0</sup>,Tyr<sup>3</sup>]octreotateTessa Brabander, Wouter A van der Zwan, Jaap J M Teunissen, et al.Oncotarget|March 31, 2018
Epidrug-induced upregulation of functional somatostatin type 2 receptors in human pancreatic neuroendocrine tumor cellsMarije J Veenstra, Peter M van Koetsveld, Fadime Dogan, et al.The Journal of Clinical Endocrinology and Metabolism|September 27, 2007
Long-term efficacy and safety of combined treatment of somatostatin analogs and pegvisomant in acromegalySebastian J C M M Neggers, Maarten O van Aken, Joop A M J L Janssen, et al.Annals of the New York Academy of Sciences|November 15, 2006
Frequent genetic changes in childhood pheochromocytomasRonald R De Krijger, Bart-Jeroen Petri, Francien H Van Nederveen, et al.Hormones & Cancer|May 19, 2019
Effects of Ketoconazole on ACTH-Producing and Non-ACTH-Producing Neuroendocrine Tumor CellsAura D Herrera-Martínez, Richard A Feelders, Wouter W de Herder, et al.Endocrine Pathology|March 16, 2022
Overview of the 2022 WHO Classification of Neuroendocrine NeoplasmsGuido Rindi, Ozgur Mete, Silvia Uccella, et al.The Journal of Clinical Endocrinology and Metabolism|March 16, 2012
Melanocortin 2 receptor-associated protein (MRAP) and MRAP2 in human adrenocortical tissues: regulation of expression and association with ACTH responsivenessJohannes Hofland, Patric J Delhanty, Jacobie Steenbergen, et al.The Journal of Clinical Endocrinology and Metabolism|January 24, 2008
Correlation of in vitro and in vivo somatotropic adenoma responsiveness to somatostatin analogs and dopamine agonists with immunohistochemical evaluation of somatostatin and dopamine receptors and electron microscopyDiego Ferone, Wouter W de Herder, Rosario Pivonello, et al.Pageof 24